Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,118.00
Bid: 12,120.00
Ask: 12,124.00
Change: 68.00 (0.56%)
Spread: 4.00 (0.033%)
Open: 11,966.00
High: 12,162.00
Low: 11,966.00
Prev. Close: 12,050.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK's NHS vaccine website crashes after jabs offered to over-45s

Tue, 13th Apr 2021 17:43

(Alliance News) - The UK National Health Service's website for booking Covid-19 vaccine appointments appeared to temporarily crash after people aged over 45 were offered jabs.

It is understood that a minority of people experienced issues with the service, including being unable to complete their booking, due to a surge in demand.

Some visitors to the site on Tuesday morning were faced with the message: "The NHS website is currently experiencing technical difficulties.

"We are working to resolve these issues. Thank you for your patience."

Other users reported being placed in a queue, with a holding screen that read: "You are in a queue. Lots of people trying to book an appointment."

Shortly after the vaccine booking site was hit by the technical issues, Vaccines Minister Nadhim Zahawi tweeted that the problem had been "fixed".

It is understood that NHS Digital were able to get the website back up and running on Tuesday morning, with all issues being resolved and people able to book appointments.

NHS Digital tweeted shortly after 10am: "We are aware that some users are experiencing delays when accessing the vaccine booking service.

"We are working to investigate the issue as a priority and minimise the impact on service users."

Technical teams worked to address the issue and users may temporarily experience longer waiting times and delay in receiving their booking confirmation.

One 47-year-old user from Bromley, south-east London, who only gave his name as Dean, encountered a problem as he tried to book a jab appointment at around 9.30am.

He said: "I seemingly booked, but the website crashed at the point of confirming contact details, i.e. giving phone number and email.

"Now, when I use my NHS number to check if my appointments exist, it will not let me find out without reference numbers for the [vaccine] bookings.

"But the paradox is, you need this from an email or text they would have sent."

Dean was able to get back on to the website after it crashed for him, explaining: "It seemed to let me get to the point of checking my booking – but obviously this is impossible without a confirmation email/text."

He tweeted at the official @NHSuk account, "hoping someone sees" to help him with the issue.

"I've already had at least four others say they have same problem," Dean claimed.

He later said he had called the NHS on the 119 number and was given his reference numbers to access the booking system.

Dean said he was told that "many people are having this problem, [including] NHS staff", that his appointments were booked, "the system is struggling" and that he should wait 24 hours to receive an email.

Jessica Rowbottom, 46, from Wakefield, West Yorkshire, also struggled to check her vaccine bookings after receiving no confirmation or reference numbers.

She said: "I work in website and application design and deal with user experience on a daily basis… it beggars belief it actually needs a confirmation number to access things anyway, especially when you've given the [date of birth] and NHS number in the first place."

The technical issues came as the NHS online booking system opened up to allow people over the age of 45 to arrange for their coronavirus vaccine as part of the start of "Phase 2" of the vaccination programme.

The NHS has previously been focused on ensuring vaccines are offered to those considered to most vulnerable to coronavirus – those aged over 50, people deemed be "clinically extremely vulnerable" and health and social care workers.

There are an estimated 3.7 million people in England aged 45 to 49.

According to the government, in total almost 40 million doses of the Pfizer and AstraZeneca vaccines have been delivered since their rollout began in the UK in December, including 32 million first jabs and more than seven million second doses.

By Tom Pilgrim, PA

source: PA

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
Today 15:54

Berenberg hikes target price on Astrazeneca

(Sharecast News) - Analysts at Berenberg hiked their target price on drugmaker Astrazeneca from 1,200.0p to 1,300.0p on Tuesday, citing the group was "instilling confidence in the revenues of tomorrow".

Read more
Today 09:51

LONDON BROKER RATINGS: AstraZeneca target raised; Antofagasta lowered

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Friday:

Read more
6 May 2024 07:46

AstraZeneca completes collaboration and investment deal with Cellectis

(Alliance News) - AstraZeneca PLC on Monday said it has completed an equity investment in clinical-stage biotechnology company Cellectis, first announced in November.

Read more
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.